Recall of specific batches of various Marks and Spencer Pink Lady apple products, due to the possible presence of Salmonella.
Alert Summary dated Wednesday, 24th June 2026.
Category 1: For Action Alert Notification: 2026.35 Product Identification: Please see table below for product details. Batch Code: Please see table below for use-by dates.
Message: The below batches of Marks and Spencer Pink Lady apple products is being recalled due to the possible presence of Salmonella.
Recall notices will be displayed at point-of-sale.
Product Name.
Product Name.
Use-by date.
M&S Food Pink Lady Apple Slices.
225g.
24/06/2026.
M&S Food Pink Lady Apple.
90g.
24/06/2026.
M&S Café Pink Lady Apple.
90g.
24/06/2026.
Nature Of Danger: People infected with Salmonella typically develop symptoms between 12 and 36 hours after infection, but this can range between 6 and 72 hours. The most common symptom is diarrhoea, which can sometimes be bloody. Other symptoms may include fever, headache, and abdominal cramps. The illness usually lasts 4 to 7 days. Diarrhoea can occasionally be severe enough to require hospital admission. The elderly, infants, and those with impaired immune systems are more likely to have a severe illness.
Retailers: Same are requested to remove the implicated batches from sale and display recall notices at point-of-sale. Consumers: Consumers are advised not to eat the implicated batches.
FSAI warn of recall of a batch of Ortiz Sardines in Olive Oil, due to the possible presence of glass pieces.
Alert Summary dated Wednesday, 24th June 2026.
Category 1: For Action. Alert Notification: 2026.36. Product Identification: Ortiz Sardines in Olive Oil; pack size: 190 g (glass jar). Batch Code: 73175G; best before date: December 2032.
Message: The above batch of Ortiz Sardines in Olive Oil is being recalled due to the possible presence of glass pieces. Recall notices will be displayed at point-of-sale.
Action Required: For Manufacturers, Wholesalers, Distributors, Caterers and Retailers:- Retailers: Same are requested to remove the implicated batch from sale and display recall notices at point-of-sale. Wholesalers / Distributors: Same are requested to contact their affected customers and recall the implicated batch and provide a point-of-sale recall notice to their retailer customers. Consumers: Consumers are advised not to eat the implicated batch.
Every time a vaccine is given, every time an anaesthetic is injected, every time a patient receives insulin, antibiotics, chemotherapy, adrenaline, morphine, or life-saving fluids through a line, there is a quiet piece of Irish history at work and it begins in Co. Dublin.
Long before modern hospitals, vaccination centres, intensive care units, emergency departments, operating theatres, and community clinics became part of everyday life, doctors faced a simple but enormous problem; how could medicine be delivered precisely into the body, beneath the skin, where it could act quickly and effectively? For much of medical history, treatments were limited by the routes available. A patient could swallow a medicine. A substance could be rubbed onto the skin. A wound could be dressed. But getting a measured treatment through the skin and into the tissues, close to the source of pain or disease, was a different challenge entirely.
Dr Francis Rynd, (1801-1861) and his hypodermic hollow needle invention.
That challenge was answered in Ireland. The late Dr Francis Rynd, (1801-1861), an Irish physician and surgeon working at the Meath Hospital in Dublin, developed a hollow needle that made hypodermic injection possible. In 1844, Rynd used his new instrument to treat a woman suffering from severe neuralgia, a crippling nerve pain that had resisted the treatments then available. Rather than relying on medicine taken by mouth, he introduced a pain-relieving solution beneath the skin, close to the affected nerves. The effect was remarkable. A patient who had been suffering intensely finally experienced relief.
It was a small procedure by modern standards, but its consequences were vast. With that act, medicine crossed a threshold. The skin was no longer an almost impenetrable barrier between doctor and disease. The body could now be reached more directly, more precisely, and often more quickly.
Dr Rynd’s newly developed instrument was not the modern disposable syringe we know today. It was a pioneering device, developed at a time when medicine was still learning how to control pain, infection, and dosage. But the principle was revolutionary; a hollow needle could carry fluid into the human body, and from that principle came a medical transformation.
Left -Right:Meath Hospital nurses photographed in 1872 and named as Fever Nurse Ms Hodgens; Night Nurse Ms Spring; Surgical Nurse Ms Murray, and Accident Nurse Ms Brazil.
Today, the hollow needle is so familiar that we often forget how extraordinary it is. It is present at birth, in childhood immunisation, in dental surgeries, in ambulances, in cancer wards, in diabetes care, in blood tests, in epidurals, in emergency medicine, in intensive care, and in operating theatres across the world.
The story became even more powerful during our recent COVID-19 pandemic. When COVID vaccines were developed and rolled out at historic speed, the world focused on the science of messenger ribonucleic acid (mRNA), viral vectors, immune response, public health logistics, cold-chain storage, and global vaccine access. All of those mattered enormously. But the final act; the moment science became protection, depended on the needle. Billions of times, in clinics, pharmacies, sports halls, hospitals, GP surgeries, care homes, schools, airports, and temporary vaccination centres, a tiny hollow needle carried a vaccine from vial to arm. That simple delivery system helped protect people from severe illness and death on a scale almost impossible to imagine. Over 13 billion COVID-19 vaccine doses have been administered globally. Each one was a modern event, shaped by cutting-edge immunology, global manufacturing, public health systems, and data science. Yet each one also belonged to a much older story: the story of a Dublin doctor who showed that medicine could be placed directly beneath the skin.
The same is true of countless other vaccines. Measles. Polio. Tetanus. Diphtheria. Influenza. HPV. Hepatitis. Pneumococcal disease. Childhood immunisation programmes across the world depend on the ability to deliver vaccines safely and reliably into the body. The needle is not the whole story of vaccination, but without it modern vaccination would not look the way it does today, and that is why Francis Rynd deserves to be better known.
Ireland has given the world poets, revolutionaries, scientists, teachers, nurses, doctors, inventors, and reformers. Among them stands a Dublin physician whose invention became one of the most important tools in the history of medicine.
While most people know the feeling of a needle; very few know the name Francis Rynd. But his legacy is everywhere. It is in the child receiving a routine vaccine. It is in the older person receiving a seasonal COVID or flu booster. It is in the patient being prepared for surgery. It is in the diabetic injecting insulin. It is in the emergency doctor administering adrenaline. It is in the cancer patient receiving treatment. It is in the drip beside a hospital bed.
A hollow needle may look ordinary. In truth, it is one of the great medical inventions and it began in Ireland and the world should remember the name Dr Francis Rynd.
“We can rebuild him. We have the technology. We can make him better than he was. Better, stronger, faster.” Afamous introductory one-liner from the TV series “The Six Million Dollar Man”.
Thirteen men were fitted with so-called “bionic penises” in Irish public hospitals last year, according to HSE figures, same released under the Freedom of Information.
The devices, officially known as penile prostheses, are surgically implanted hydraulic systems that can be manually inflated to help men suffering from serious erectile dysfunction regain sexual function.
The number of procedures rose by more than 60% last year, with patients diagnosed with conditions including “failure of genital response” and “impotence of organic origin”.
The HSE said the procedures are carried out only where clinically indicated, but could not provide a central cost. Based on private UK pricing of around €34,800 per procedure, the total cost may have exceeded €450,000.
A previous Irish Medical Journal study found 86% of patients who received the treatment in Irish hospitals between 2008 and 2017 were satisfied with the outcome, although complications such as infection, erosion and device failure were also reported.
So there you have it; amid all the talk of health service delays within the HSE, at least one part of the system appears to be standing up to pressure. ☺☻☺☻
Food Safety Authority of Ireland Update recall of specific batches of various French Brie products due to the presence of Listeria monocytogenes.
Alert Summary dated Tuesday, June 23rd 2026.
Category 1: For Action Alert Notification: 2026.34 (Update 1) Product Identification: Traditional Cheese Company French Brie; pack size: 160g Batch Code Use-by Date: 10/07/2026
Message: Further to FSAI food alert 2026.34, the correct use-by date for the implicated batch of Traditional Cheese Company French Brie being recalled due to the presence of Listeria monocytogenes is 10/07/2026.
Recall notices will be displayed at point-of-sale.
Nature Of Danger: Symptoms of Listeria monocytogenes infection can include mild flu-like symptoms, or gastrointestinal symptoms such as nausea, vomiting and diarrhoea. In rare cases, the infection can be more severe, causing serious complications. Some people are more vulnerable to Listeria monocytogenes infections, including pregnant women, babies, and people with weakened immune systems, including the elderly. The incubation period (time between initial infection and first symptoms appearing) is on average 3 weeks but can range between 3 and 70 days.
Action Required: Manufacturers, wholesalers, distributors, caterers & retailers. Retailers: Same are requested to remove the implicated batch from sale and display recall notices at point-of-sale. Wholesalers/Distributors: Same are requested to contact their affected customers and recall the implicated batch and provide a point-of-sale recall notice to their retailer customers. Consumers: Consumers are advised not to eat the implicated batch.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.AcceptRead More
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
Recent Comments